RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Zivo Bioscience Stock

Zivo Bioscience Debt 2024

Zivo Bioscience Debt

-0.03 USD

Ticker

ZIVO

ISIN

US98978N1019

In 2024, Zivo Bioscience's total debt was -0.03 USD, a -97.8% change from the -1.56 USD total debt recorded in the previous year.

Zivo Bioscience Aktienanalyse

What does Zivo Bioscience do?

Zivo Bioscience Inc is a biotechnology company that was founded in 2008. The company is based in Keego Harbor, Michigan, USA. It specializes in the development and production of animal feed, nutritional supplements, and medications from plant sources. The founders of the company recognized the potential of microalgae as a food source for animals and began conducting extensive research campaigns on this topic. The algae are rich in proteins, Omega-3, vitamins, and minerals, making them an excellent food source for livestock. Zivo Bioscience Inc's business model is based on the production of food and nutritional supplements for livestock. The company's goal is to offer a cost-effective alternative to conventional animal feed products that have higher quality and nutritional value. The company holds several patents for its technology, which allows it to develop these high-quality food products. Zivo Bioscience Inc has three different business segments: animal feed, human nutritional supplements, and pharmaceutical products. The animal feed segment is the company's largest business segment. The products include cattle feed, poultry feed, and swine feed. The human nutritional supplements are high-quality supplements made from the company's crop plants. These include products such as Omega-3 supplements, immune system boosters, and antioxidants. The pharmaceutical segment of the company focuses on the development of medications for various applications, particularly for the fight against inflammation and cancer. Zivo Bioscience Inc has launched several plant-based products on the market. The products for livestock include ZivoProtein and ZivoAlgae. ZivoProtein is a high-quality protein derived from microalgae that can be used in various animal feed products. ZivoAlgae is a blend of different microalgae species that can be used as a nutritional supplement for livestock. The products for human nutritional supplements include ZivoChews, ZivoBar, and ZivoEPA+DHA. ZivoChews and ZivoBar are snack products made from plant sources and contain various nutrients, including proteins, Omega-3 fatty acids, and antioxidants. ZivoEPA+DHA is a high-quality Omega-3 supplement. In the pharmaceutical field, the company has developed ZivoBort and ZivoBurster. ZivoBort is a potential medication aimed at fighting inflammation, while ZivoBurster is a potential medication for combating cancer. Zivo Bioscience Inc has established several business relationships in recent years to sell its products. The company has formed partnerships with animal feed company NutriQuest and pharmaceutical company PharmCoRx. Zivo Bioscience Inc has also collaborated with the University of Arizona and the University of Massachusetts to conduct research in the field of plant biotechnology. Overall, Zivo Bioscience Inc is an innovative company specializing in the development of high-quality food and nutritional supplements from plant sources. The company has already launched several products on the market and is working on developing new products. With its research efforts and business relationships, the company is well-positioned to realize its vision of cost-effective and nutritious animal feed products. Zivo Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Zivo Bioscience's Debt Structure

Zivo Bioscience's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Zivo Bioscience's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Zivo Bioscience’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Zivo Bioscience’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Zivo Bioscience stock

What is the debt of Zivo Bioscience this year?

Zivo Bioscience has a debt level of -0.03 USD this year.

What was the debt of Zivo Bioscience compared to the previous year?

The debt of Zivo Bioscience has increased by -97.8% compared to the previous year dropped.

What are the consequences of high debt for investors in Zivo Bioscience?

High debt can pose a risk for investors of Zivo Bioscience, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Zivo Bioscience?

Low debt means that Zivo Bioscience has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Zivo Bioscience affect the company?

An increase in debt of Zivo Bioscience can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Zivo Bioscience affect the company?

A reduction in debt of Zivo Bioscience can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Zivo Bioscience?

Some factors that can influence the debt of Zivo Bioscience include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Zivo Bioscience so important for investors?

The debts of Zivo Bioscience are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Zivo Bioscience take to change the debt?

To change the debt, Zivo Bioscience can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Zivo Bioscience pay?

Over the past 12 months, Zivo Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zivo Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Zivo Bioscience?

The current dividend yield of Zivo Bioscience is .

When does Zivo Bioscience pay dividends?

Zivo Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Zivo Bioscience?

Zivo Bioscience paid dividends every year for the past 0 years.

What is the dividend of Zivo Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Zivo Bioscience located?

Zivo Bioscience is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Zivo Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zivo Bioscience from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Zivo Bioscience pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Zivo Bioscience in the year 2023?

In the year 2023, Zivo Bioscience distributed 0 USD as dividends.

In which currency does Zivo Bioscience pay out the dividend?

The dividends of Zivo Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Zivo Bioscience

Our stock analysis for Zivo Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zivo Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.